Urotensin II in Chronic Kidney Diseases and Kidney Transplants

Urotensin II in Chronic Kidney Diseases

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01098799

Enrollment

110

Registered

2010-04-05

Start date

2010-04-30

Completion date

2010-07-31

Last updated

2013-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Disease

Keywords

Urotensin II,Chronic renal disease

Brief summary

The investigators are planning to study the serum level of Urotensin II in chronic kidney disease patients, kidney transplants, and healthy controls.

Detailed description

The investigators will determine the urotensin II levels in Chronic kidney disease patients, kidney transplants, and healthy controls.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 90 Years

Healthy volunteers

Yes

Inclusion criteria

* Age more than 18

Exclusion criteria

* Inability to give a written consent

Design outcomes

Primary

Measure	Time frame	Description
serum Urotensin II(UII)level	at enrollment	We tried to compare UII level in normal, chronic kidney disease and kidney transplant patients group

Countries

Turkey (Türkiye)

Outcome results